Exploring the epigenetic regulation of telomerase reverse transcriptase (TERT) in human cancer cell lines

Mol Oncol. 2020 Oct;14(10):2355-2357. doi: 10.1002/1878-0261.12798. Epub 2020 Sep 19.

Abstract

Telomerase regulation, including TERT promoter methylation, has been of long-standing interest to cancer biologists. Rowland et al. have now vastly expanded their ongoing characterization of TERT promoter methylation in cancer cells, analyzing the methylation patterns of 833 cell lines from 23 human cancers. They document a highly conserved pattern of hypomethylation around the proximal promoter, as well as a more heterogeneous region of hypermethylation further upstream, both associated with active TERT expression in cancer cells. They further describe the interplay between activating TERT promoter mutations and allelic methylation and transcription patterns. This valuable dataset represents the most extensive characterization of TERT promoter methylation in cancer cells to date and will help guide the future study of transcriptional regulation of telomerase. Comment on: https://doi.org/10.1002/1878-0261.12786.

Keywords: TERT promoter methylation; TERT promoter mutation; epigenetic regulation; monoallelic gene expression; monoallelic methylation; telomerase reverse transcriptase.

Publication types

  • Comment

MeSH terms

  • Alleles
  • Cell Line, Tumor
  • DNA Methylation / genetics
  • Epigenesis, Genetic
  • Humans
  • Mutation
  • Neoplasms* / genetics
  • Telomerase* / genetics
  • Telomerase* / metabolism

Substances

  • TERT protein, human
  • Telomerase